Literature DB >> 24750398

Altered lysophosphatidic acid (LPA) receptor expression during hepatic regeneration in a mouse model of partial hepatectomy.

Kerri A Simo1, David J Niemeyer, Erin M Hanna, Jacob H Swet, Kyle J Thompson, David Sindram, David A Iannitti, Ashley L Eheim, Eugene Sokolov, Valentina Zuckerman, Iain H McKillop.   

Abstract

BACKGROUND: Hepatic regeneration requires coordinated signal transduction for efficient restoration of functional liver mass. This study sought to determine changes in lysophosphatidic acid (LPA) and LPA receptor (LPAR) 1-6 expression in regenerating liver following two-thirds partial hepatectomy (PHx).
METHODS: Liver tissue and blood were collected from male C57BL/6 mice following PHx. Circulating LPA was measured by enzyme-linked immunosorbent assay (ELISA) and hepatic LPAR mRNA and protein expression were determined.
RESULTS: Circulating LPA increased 72 h after PHx and remained significantly elevated for up to 7 days post-PHx. Analysis of LPAR expression after PHx demonstrated significant increases in LPAR1, LPAR3 and LPAR6 mRNA and protein in a time-dependent manner for up to 7 days post-PHx. Conversely, LPAR2, LPAR4 and LPAR5 mRNA were barely detected in normal liver and did not significantly change after PHx. Changes in LPAR1 expression were confined to non-parenchymal cells following PHx.
CONCLUSIONS: Liver regeneration following PHx is associated with significant changes in circulating LPA and hepatic LPAR1, LPAR3 and LPAR6 expression in a time- and cell-dependent manner. Furthermore, changes in LPA-LPAR post-PHx occur after the first round of hepatocyte division is complete.
© 2013 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24750398      PMCID: PMC4048075          DOI: 10.1111/hpb.12176

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  36 in total

1.  Lysophosphatidic acid enhances collagen gel contraction by hepatic stellate cells: association with rho-kinase.

Authors:  M Yanase; H Ikeda; A Matsui; H Maekawa; E Noiri; T Tomiya; M Arai; T Yano; M Shibata; M Ikebe; K Fujiwara; M Rojkind; I Ogata
Journal:  Biochem Biophys Res Commun       Date:  2000-10-14       Impact factor: 3.575

Review 2.  Lysophosphatidic acid is a lipid mediator with wide range of biological activities. Biosynthetic pathways and mechanism of action.

Authors:  I N Berdichevets; T V Tyazhelova; Kh R Shimshilashvili; E I Rogaev
Journal:  Biochemistry (Mosc)       Date:  2010-09       Impact factor: 2.487

3.  Efficient trafficking of MDR1/P-glycoprotein to apical canalicular plasma membranes in HepG2 cells requires PKA-RIIalpha anchoring and glucosylceramide.

Authors:  Kacper A Wojtal; Erik de Vries; Dick Hoekstra; Sven C D van Ijzendoorn
Journal:  Mol Biol Cell       Date:  2006-05-24       Impact factor: 4.138

4.  Regulation of hepatic stellate cell differentiation by the neurotrophin receptor p75NTR.

Authors:  Melissa A Passino; Ryan A Adams; Shoana L Sikorski; Katerina Akassoglou
Journal:  Science       Date:  2007-03-30       Impact factor: 47.728

5.  AKAP350 Is involved in the development of apical "canalicular" structures in hepatic cells HepG2.

Authors:  Stella M Mattaloni; Elena Kolobova; Cristián Favre; Raúl A Marinelli; James R Goldenring; Maria C Larocca
Journal:  J Cell Physiol       Date:  2012-01       Impact factor: 6.384

Review 6.  Signalling from adenosine receptors to mitogen-activated protein kinases.

Authors:  Gunnar Schulte; Bertil B Fredholm
Journal:  Cell Signal       Date:  2003-09       Impact factor: 4.315

7.  Hepatocellular carcinoma associated lipid metabolism reprogramming.

Authors:  Nicholas James Skill; Rachael E Scott; Jianmin Wu; Mary A Maluccio
Journal:  J Surg Res       Date:  2009-09-25       Impact factor: 2.192

Review 8.  The structure and function of G-protein-coupled receptors.

Authors:  Daniel M Rosenbaum; Søren G F Rasmussen; Brian K Kobilka
Journal:  Nature       Date:  2009-05-21       Impact factor: 49.962

9.  Effects of lysophosphatidic acid on proliferation of stellate cells and hepatocytes in culture.

Authors:  H Ikeda; Y Yatomi; M Yanase; H Satoh; A Nishihara; M Kawabata; K Fujiwara
Journal:  Biochem Biophys Res Commun       Date:  1998-07-20       Impact factor: 3.575

10.  Lysophosphatidic acid receptor expression and function in human hepatocellular carcinoma.

Authors:  Eugene Sokolov; Ashley L Eheim; William A Ahrens; Tracy L Walling; Jacob H Swet; Matthew T McMillan; Kerri A Simo; Kyle J Thompson; David Sindram; Iain H McKillop
Journal:  J Surg Res       Date:  2012-11-15       Impact factor: 2.192

View more
  6 in total

1.  Sesamol protects against liver fibrosis induced in rats by modulating lysophosphatidic acid receptor expression and TGF-β/Smad3 signaling pathway.

Authors:  Nesma A Abd Elrazik; Mohamed El-Mesery; Mamdouh M El-Shishtawy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-06-01       Impact factor: 3.195

2.  Lysophosphatidic acid alters the expression profiles of angiogenic factors, cytokines, and chemokines in mouse liver sinusoidal endothelial cells.

Authors:  Chia-Hung Chou; Shou-Lun Lai; Cheng-Maw Ho; Wen-Hsi Lin; Chiung-Nien Chen; Po-Huang Lee; Fu-Chuo Peng; Sung-Hsin Kuo; Szu-Yuan Wu; Hong-Shiee Lai
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

3.  Lysophosphatidic acid counteracts glucagon-induced hepatocyte glucose production via STAT3.

Authors:  Evan P Taddeo; Stefan R Hargett; Sujoy Lahiri; Marin E Nelson; Jason A Liao; Chien Li; Jill K Slack-Davis; Jose L Tomsig; Kevin R Lynch; Zhen Yan; Thurl E Harris; Kyle L Hoehn
Journal:  Sci Rep       Date:  2017-03-09       Impact factor: 4.379

4.  Expression and function of lysophosphatidic acid receptors (LPARs) 1 and 3 in human hepatic cancer progenitor cells.

Authors:  Valentina Zuckerman; Eugene Sokolov; Jacob H Swet; William A Ahrens; Victor Showlater; David A Iannitti; Iain H Mckillop
Journal:  Oncotarget       Date:  2016-01-19

5.  Lysophosphatidic acid protects against acetaminophen-induced acute liver injury.

Authors:  Geon Ho Bae; Sung Kyun Lee; Hyung Sik Kim; Mingyu Lee; Ha Young Lee; Yoe-Sik Bae
Journal:  Exp Mol Med       Date:  2017-12-08       Impact factor: 8.718

6.  EDG2 enhanced the progression of hepatocellular carcinoma by LPA/PI3K/AKT/ mTOR signaling.

Authors:  Meng Xu; Zhikui Liu; Cong Wang; Bowen Yao; Xin Zheng
Journal:  Oncotarget       Date:  2017-08-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.